PTGS2 and neoplasm: Therefore, targeting mechanisms controlling neoplastic COX-2 regulation in stromal and epithelial elements of tumours may provide an alternative in tumour-specific COX-2 inhibition, avoiding the side effects related to systemic COX-2 inhibition.